Glancing Back at 2018 FDA Approvals In Eyecare

FDA approves drug for use in fighting Alzheimer's despite lingering questions from key panelПодробнее

Why FDA Approval MattersПодробнее

FDA issues warning over Delsam Pharma's eye ointmentПодробнее

Looking Ahead: New Drug Approvals for 2017Подробнее

FDA Approvals in 2015: Year in ReviewПодробнее

FDA Approval of Extended Range Intraocular LensПодробнее

FDA 510 (k) Approval Services On Medical Device - Operon StrategistПодробнее

Co-Management Update 2022Подробнее

Update on Diabetes Research & Treatment: What the Optometrist Needs to Know with Dr. Paul ChousПодробнее

Info Day 2018: Professor John Grigg - 'Exploring outcome measures in inherited retinal dystrophies'Подробнее

Repurposing FDA-approved drugs for treatment of COVID-19Подробнее

The Holy Grail: Topical Treatments for PresbyopiaПодробнее

What Drug Approvals Mean for Biotech InvestorsПодробнее

Updates on the Management of Diabetic RetinopathyПодробнее

post-approval surveillance of drugsПодробнее

Alzheimer's drug approved by the FDA💡Подробнее

Misunderstandings in KC Detection and Interventions 04 07 21Подробнее

FDA issues warning about DELSAM Pharma's Artificial Eye OintmentПодробнее

QUALITY OF CLINICAL TRIAL EVIDENCE VARIES GREATLY IN F-D-A'S DRUG APPROVAL PROCESSПодробнее